Abstract:Alzheimer's disease (AD) is a chronic neurodegenerative, and abnormal aggregation of the neurotoxic beta amyloid (A beta) peptide is an early event in AD. The present study aimed to determine the correlation between the nicotinic acetylcholine receptor alpha 7 subunit (alpha 7 nAChR) and A beta in the brains of patients with AD, and to investigate whether the increased expression levels of the alpha 7 nAChR could alter the neurotoxicity of A beta. The expression levels of alpha 7 nAChR and A beta in the brains of patients with AD and healthy brains were analyzed using immunofluorescence. Moreover, SH-SY5Y cells were used to stably overexpress or silence alpha 7 nAChR expression levels, prior to the treatment with or without 1 mu mol/l A beta(1-42) oligomer (A beta O). The mRNA and protein expression levels of alpha 7 nAChR, synaptophysin (SYP), postsynaptic density of 95 kDa (PSD-95) and synaptosomal-associated protein of 25 kDa (SNAP-25) were subsequently analyzed using reverse transcription-quantitative PCR and western blotting. In addition, the concentration of acetylcholine (ACh) and the activity of acetylcholinesterase (AChE) were analyzed using spectrophotometry, while the cell apoptotic rate was determined using flow cytometry. The expression of A beta in the brains of patients with AD was found to be significantly increased, whereas the expression of alpha 7 nAChR was significantly decreased compared with the healthy control group. In vitro, the expression levels of alpha 7 nAChR were significantly increased or decreased following the overexpression or silencing of the gene, respectively. Consistent with these observations, the mRNA and protein expression levels of SYP, PSD-95 and SNAP-25 were also significantly increased following the overexpression of alpha 7 nAChR and decreased following the genetic silencing of the receptor. In untransfected or negative control cells, the expression levels of these factors and the apoptotic rate were significantly reduced following the exposure to A beta O, which was found to be attenuated by alpha 7 nAChR overexpression, but potentiated by alpha 7 nAChR RNA silencing. However, no significant differences were observed in either the ACh concentration or AChE activity following transfection. Collectively, these findings suggested that alpha 7 nAChR may protect the brains of patients with AD against A beta, as alpha 7 nAChR overexpression increased the expression levels of SYP, SNAP-25 and PSD-95, and attenuated the inhibitory effect of A beta on the expression of these synaptic proteins and cell apoptosis. Overall, this indicated that alpha 7 nAChR may serve an important neuroprotective role in AD.

6beta-acetoxy nortropane regulated processing of amyloid precursor protein in CHOm1 cells and rat brain.

Simultaneous Changes in Secretory Amyloid Precursor Protein and Β-Amyloid Peptide Release from Rat Hippocampus by Activation of Muscarinic Receptors

Activation of Α7 Nicotinic Acetylcholine Receptor by Its Selective Agonist Improved Learning and Memory of Amyloid Precursor Protein/Presenilin 1 (APP/PS1) Mice Via the Nrf2/HO-1 Pathway.

A New Chiral Pyrrolyl Alpha-Nitronyl Nitroxide Radical Attenuates Beta-Amyloid Deposition And Rescues Memory Deficits In A Mouse Model Of Alzheimer Disease

A New Chiral Pyrrolyl α-Nitronyl Nitroxide Radical Attenuates β-Amyloid Deposition and Rescues Memory Deficits in a Mouse Model of Alzheimer Disease

[Inhibitory Effect of 6 Beta-Acetoxy Nortropane on Respiration].

Activation of α7 nAChR by PNU-282987 improves synaptic and cognitive functions through restoring the expression of synaptic-associated proteins and the CaM-CaMKII-CREB signaling pathway.

The effects expression of α7 neuronal nicotine receptor agonist PNU282987 on DYN-Ⅰ Protein in hippocampus of APP/PS1 Mice

P3–349: Inhibition of Secreted Alpha–app and Enhanced Neurotoxication of Beta–amyloid Peptide by Interference of Nicotinic Receptor Alpha7 Mrna in SH–SY5Y Cells

Activation of 7 nAChR by PNU-282987 improves synaptic and cognitive functions through restoring the expression of synaptic-associated proteins and the CaM-CaMKII-CREB signaling pathway

Protective Effects Of Chaga Medicinal Mushroom, Inonotus Obliquus (Agaricomycetes), Extract On Beta-Amyloid-Induced Neurotoxicity In Pc12 Cells And Aging Rats: In Vitro And In Vivo Studies

Preventing Expression Of The Nicotinic Receptor Subunit Alpha 7 In Sh-Sy5y Cells With Interference Rna Indicates That This Receptor May Protect Against The Neurotoxicity Of A Beta

Activation of Α7 Nicotinic Receptor Affects APP Processing by Regulating Secretase Activity in SH-EP1-α7 Nachr-Happ695 Cells

The effects expression of α7 neuronal nicotine receptor agonist PNU282987 on AP180 protein in hippocampus of APP/PS1 Mice

Inhibiting Gene Expression of Α3 Nicotinic Receptor in SH-SY5Y Cells with the Effects on APP Metabolism and Antioxidation in Alzheimer's Disease

Nicotine Modulates Expression of Amyloid Precursor Protein and Amyloid Precursor-Like Protein 2 in Mouse Brain and in SH-SY5Y Neuroblastoma Cells.

Neuroprotective effects of β7 neuronal acetylcholine receptor and its roles in the pathogenesis of Alzheimer's disease

Amyloid Precursor Protein Gene Mutated at Swedish 670/671 Sites in Vitro Induces Changed Expression of Nicotinic Acetylcholine Receptors and Neurotoxicity

Expression levels of the 7 nicotinic acetylcholine receptor in the brains of patients with Alzheimer's disease and their effect on synaptic proteins in SH-SY5Y cells

[Neuroprotective Effects of Alpha7 Neuronal Acetylcholine Receptor and Its Roles in the Pathogenesis of Alzheimer's Disease].

Preventing Expression of the Nicotinic Receptor Subunit α7 in SH-SY5Y Cells with Interference RNA Indicates that this Receptor may Protect Against the Neurotoxicity of Aβ